These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8031157)

  • 1. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C; Matsumoto K; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion].
    Miyagami M; Tazoe M; Tsubokawa T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):275-80. PubMed ID: 2154161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intratumoral pharmacokinetics following intraarterial administration of MCNU in patients with malignant gliomas].
    Yamasaki T; Nagao S; Kagawa T; Konishi S; Akiyama Y; Fukuda M; Kimura Y; Moritake K
    No Shinkei Geka; 1995 Nov; 23(11):963-9. PubMed ID: 7477717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
    Watanabe M; Takeda N; Tanaka R
    Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized study of initial treatment with radiation.MCNU or radiation.MCNU.interferon-beta for malignant glioma. Hiroshima Brain Tumor Study Group].
    Kiya K; Uozumi T; Kurisu K; Inagawa T; Ohta M; Kajikawa H; Kawashima K; Kitaoka T; Goishi A; Kodama Y
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):221-6. PubMed ID: 2405777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].
    Wakabayashi T; Yoshida J; Kito A; Inoue I; Kobayashi T; Kageyama N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2729-37. PubMed ID: 6095764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
    Muraoka K
    No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative intraperitoneal versus intravenous carboplatin chemotherapy for advanced gastric cancer, pharmacokinetics and drug accumulation study].
    Wang J; Chen J; Ma S
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):300-2. PubMed ID: 11038765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
    Sasajima T; Mineura K; Kowada M; Watanabe A; Takeda O
    No To Shinkei; 1996 Jul; 48(7):653-8. PubMed ID: 8753001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of a combination therapy of irradiation, MCNU, carboplatin (CBDCA) and IFN-beta (MCI therapy) for gliomas].
    Shinohara C; Matsumoto K; Nakagawa M; Ono Y; Higashi H; Tsuno K; Maeshiro T; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2067-9. PubMed ID: 8215484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraperitoneal and intrathoracic administration of hydroxyapatite-carboplatin (HAp-CBDCA)].
    Mohri N; Mizuno I; Akamo Y; Takeyama H; Manabe T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1791-3. PubMed ID: 10560396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis].
    Mizuno I; Yasui T; Takeyama H; Ishikawa M; Terada J; Mohri N; Ueda T; Sumita N; Kobayashi K; Akamo Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1598-601. PubMed ID: 7574769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion.
    Hodozuka A; Sako K; Nakai H; Tomabechi M; Suzuki N; Yonemasu Y
    J Neurooncol; 1993 Jan; 15(1):79-86. PubMed ID: 8455066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
    Morgan RJ; Synold TW; Gandara D; Muggia F; Scudder S; Reed E; Margolin K; Raschko J; Leong L; Shibata S; Tetef M; Vasilev S; McGonigle K; Longmate J; Yen Y; Chow W; Somlo G; Carroll M; Doroshow JH
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):283-9. PubMed ID: 15184995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
    Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
    J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.